Request for Covid-19 Impact Assessment of this Report
The United States Meningitis Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Meningitis Vaccine market, reaching US$ million by the year 2028. As for the Europe Meningitis Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Meningitis Vaccine players cover GlaxoSmithKline, Baxter International, Sanofi Pasteur, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Meningitis A+C
Meningitis ACWY135
Meningitis B
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medical Care
Hospital
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningitis Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Meningitis Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Meningitis Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Meningitis Vaccine Segment by Type
2.2.1 Meningitis A+C
2.2.2 Meningitis ACWY135
2.2.3 Meningitis B
2.3 Meningitis Vaccine Sales by Type
2.3.1 Global Meningitis Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Meningitis Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Meningitis Vaccine Sale Price by Type (2017-2022)
2.4 Meningitis Vaccine Segment by Application
2.4.1 Medical Care
2.4.2 Hospital
2.5 Meningitis Vaccine Sales by Application
2.5.1 Global Meningitis Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Meningitis Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Meningitis Vaccine Sale Price by Application (2017-2022)
3 Global Meningitis Vaccine by Company
3.1 Global Meningitis Vaccine Breakdown Data by Company
3.1.1 Global Meningitis Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Meningitis Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Meningitis Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Meningitis Vaccine Revenue by Company (2020-2022)
3.2.2 Global Meningitis Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Meningitis Vaccine Sale Price by Company
3.4 Key Manufacturers Meningitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningitis Vaccine Product Location Distribution
3.4.2 Players Meningitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Meningitis Vaccine by Geographic Region
4.1 World Historic Meningitis Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Meningitis Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Meningitis Vaccine Annual Revenue by Geographic Region
4.2 World Historic Meningitis Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Meningitis Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Meningitis Vaccine Annual Revenue by Country/Region
4.3 Americas Meningitis Vaccine Sales Growth
4.4 APAC Meningitis Vaccine Sales Growth
4.5 Europe Meningitis Vaccine Sales Growth
4.6 Middle East & Africa Meningitis Vaccine Sales Growth
5 Americas
5.1 Americas Meningitis Vaccine Sales by Country
5.1.1 Americas Meningitis Vaccine Sales by Country (2017-2022)
5.1.2 Americas Meningitis Vaccine Revenue by Country (2017-2022)
5.2 Americas Meningitis Vaccine Sales by Type
5.3 Americas Meningitis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningitis Vaccine Sales by Region
6.1.1 APAC Meningitis Vaccine Sales by Region (2017-2022)
6.1.2 APAC Meningitis Vaccine Revenue by Region (2017-2022)
6.2 APAC Meningitis Vaccine Sales by Type
6.3 APAC Meningitis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Meningitis Vaccine by Country
7.1.1 Europe Meningitis Vaccine Sales by Country (2017-2022)
7.1.2 Europe Meningitis Vaccine Revenue by Country (2017-2022)
7.2 Europe Meningitis Vaccine Sales by Type
7.3 Europe Meningitis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Meningitis Vaccine by Country
8.1.1 Middle East & Africa Meningitis Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Meningitis Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Meningitis Vaccine Sales by Type
8.3 Middle East & Africa Meningitis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningitis Vaccine
10.3 Manufacturing Process Analysis of Meningitis Vaccine
10.4 Industry Chain Structure of Meningitis Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningitis Vaccine Distributors
11.3 Meningitis Vaccine Customer
12 World Forecast Review for Meningitis Vaccine by Geographic Region
12.1 Global Meningitis Vaccine Market Size Forecast by Region
12.1.1 Global Meningitis Vaccine Forecast by Region (2023-2028)
12.1.2 Global Meningitis Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningitis Vaccine Forecast by Type
12.7 Global Meningitis Vaccine Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Meningitis Vaccine Product Offered
13.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Baxter International
13.2.1 Baxter International Company Information
13.2.2 Baxter International Meningitis Vaccine Product Offered
13.2.3 Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Baxter International Main Business Overview
13.2.5 Baxter International Latest Developments
13.3 Sanofi Pasteur
13.3.1 Sanofi Pasteur Company Information
13.3.2 Sanofi Pasteur Meningitis Vaccine Product Offered
13.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Pasteur Main Business Overview
13.3.5 Sanofi Pasteur Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Meningitis Vaccine Product Offered
13.4.3 Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Meningitis Vaccine Product Offered
13.5.3 Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Meningitis Vaccine Product Offered
13.6.3 Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Hualan
13.7.1 Hualan Company Information
13.7.2 Hualan Meningitis Vaccine Product Offered
13.7.3 Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hualan Main Business Overview
13.7.5 Hualan Latest Developments
13.8 Zhejiang Tianyuan
13.8.1 Zhejiang Tianyuan Company Information
13.8.2 Zhejiang Tianyuan Meningitis Vaccine Product Offered
13.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Zhejiang Tianyuan Main Business Overview
13.8.5 Zhejiang Tianyuan Latest Developments
13.9 Beijing Tiantan Biological
13.9.1 Beijing Tiantan Biological Company Information
13.9.2 Beijing Tiantan Biological Meningitis Vaccine Product Offered
13.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Beijing Tiantan Biological Main Business Overview
13.9.5 Beijing Tiantan Biological Latest Developments
14 Research Findings and Conclusion
Table 1. Meningitis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Meningitis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Meningitis A+C
Table 4. Major Players of Meningitis ACWY135
Table 5. Major Players of Meningitis B
Table 6. Global Meningitis Vaccine Sales by Type (2017-2022) & (K MT)
Table 7. Global Meningitis Vaccine Sales Market Share by Type (2017-2022)
Table 8. Global Meningitis Vaccine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Meningitis Vaccine Revenue Market Share by Type (2017-2022)
Table 10. Global Meningitis Vaccine Sale Price by Type (2017-2022) & (USD/MT)
Table 11. Global Meningitis Vaccine Sales by Application (2017-2022) & (K MT)
Table 12. Global Meningitis Vaccine Sales Market Share by Application (2017-2022)
Table 13. Global Meningitis Vaccine Revenue by Application (2017-2022)
Table 14. Global Meningitis Vaccine Revenue Market Share by Application (2017-2022)
Table 15. Global Meningitis Vaccine Sale Price by Application (2017-2022) & (USD/MT)
Table 16. Global Meningitis Vaccine Sales by Company (2020-2022) & (K MT)
Table 17. Global Meningitis Vaccine Sales Market Share by Company (2020-2022)
Table 18. Global Meningitis Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Meningitis Vaccine Revenue Market Share by Company (2020-2022)
Table 20. Global Meningitis Vaccine Sale Price by Company (2020-2022) & (USD/MT)
Table 21. Key Manufacturers Meningitis Vaccine Producing Area Distribution and Sales Area
Table 22. Players Meningitis Vaccine Products Offered
Table 23. Meningitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Meningitis Vaccine Sales by Geographic Region (2017-2022) & (K MT)
Table 27. Global Meningitis Vaccine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Meningitis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Meningitis Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Meningitis Vaccine Sales by Country/Region (2017-2022) & (K MT)
Table 31. Global Meningitis Vaccine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Meningitis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Meningitis Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Meningitis Vaccine Sales by Country (2017-2022) & (K MT)
Table 35. Americas Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 36. Americas Meningitis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 38. Americas Meningitis Vaccine Sales by Type (2017-2022) & (K MT)
Table 39. Americas Meningitis Vaccine Sales Market Share by Type (2017-2022)
Table 40. Americas Meningitis Vaccine Sales by Application (2017-2022) & (K MT)
Table 41. Americas Meningitis Vaccine Sales Market Share by Application (2017-2022)
Table 42. APAC Meningitis Vaccine Sales by Region (2017-2022) & (K MT)
Table 43. APAC Meningitis Vaccine Sales Market Share by Region (2017-2022)
Table 44. APAC Meningitis Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Meningitis Vaccine Revenue Market Share by Region (2017-2022)
Table 46. APAC Meningitis Vaccine Sales by Type (2017-2022) & (K MT)
Table 47. APAC Meningitis Vaccine Sales Market Share by Type (2017-2022)
Table 48. APAC Meningitis Vaccine Sales by Application (2017-2022) & (K MT)
Table 49. APAC Meningitis Vaccine Sales Market Share by Application (2017-2022)
Table 50. Europe Meningitis Vaccine Sales by Country (2017-2022) & (K MT)
Table 51. Europe Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 52. Europe Meningitis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 54. Europe Meningitis Vaccine Sales by Type (2017-2022) & (K MT)
Table 55. Europe Meningitis Vaccine Sales Market Share by Type (2017-2022)
Table 56. Europe Meningitis Vaccine Sales by Application (2017-2022) & (K MT)
Table 57. Europe Meningitis Vaccine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Meningitis Vaccine Sales by Country (2017-2022) & (K MT)
Table 59. Middle East & Africa Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Meningitis Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Meningitis Vaccine Sales by Type (2017-2022) & (K MT)
Table 63. Middle East & Africa Meningitis Vaccine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Meningitis Vaccine Sales by Application (2017-2022) & (K MT)
Table 65. Middle East & Africa Meningitis Vaccine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Meningitis Vaccine
Table 67. Key Market Challenges & Risks of Meningitis Vaccine
Table 68. Key Industry Trends of Meningitis Vaccine
Table 69. Meningitis Vaccine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Meningitis Vaccine Distributors List
Table 72. Meningitis Vaccine Customer List
Table 73. Global Meningitis Vaccine Sales Forecast by Region (2023-2028) & (K MT)
Table 74. Global Meningitis Vaccine Sales Market Forecast by Region
Table 75. Global Meningitis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Meningitis Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Meningitis Vaccine Sales Forecast by Country (2023-2028) & (K MT)
Table 78. Americas Meningitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Meningitis Vaccine Sales Forecast by Region (2023-2028) & (K MT)
Table 80. APAC Meningitis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Meningitis Vaccine Sales Forecast by Country (2023-2028) & (K MT)
Table 82. Europe Meningitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Meningitis Vaccine Sales Forecast by Country (2023-2028) & (K MT)
Table 84. Middle East & Africa Meningitis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Meningitis Vaccine Sales Forecast by Type (2023-2028) & (K MT)
Table 86. Global Meningitis Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Meningitis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Meningitis Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Meningitis Vaccine Sales Forecast by Application (2023-2028) & (K MT)
Table 90. Global Meningitis Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Meningitis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Meningitis Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 93. GlaxoSmithKline Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Meningitis Vaccine Product Offered
Table 95. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Baxter International Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter International Meningitis Vaccine Product Offered
Table 100. Baxter International Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 101. Baxter International Main Business
Table 102. Baxter International Latest Developments
Table 103. Sanofi Pasteur Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Sanofi Pasteur Meningitis Vaccine Product Offered
Table 105. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 106. Sanofi Pasteur Main Business
Table 107. Sanofi Pasteur Latest Developments
Table 108. Merck Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck Meningitis Vaccine Product Offered
Table 110. Merck Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 111. Merck Main Business
Table 112. Merck Latest Developments
Table 113. Novartis Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis Meningitis Vaccine Product Offered
Table 115. Novartis Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 116. Novartis Main Business
Table 117. Novartis Latest Developments
Table 118. Pfizer Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Meningitis Vaccine Product Offered
Table 120. Pfizer Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
Table 123. Hualan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Hualan Meningitis Vaccine Product Offered
Table 125. Hualan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 126. Hualan Main Business
Table 127. Hualan Latest Developments
Table 128. Zhejiang Tianyuan Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Zhejiang Tianyuan Meningitis Vaccine Product Offered
Table 130. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 131. Zhejiang Tianyuan Main Business
Table 132. Zhejiang Tianyuan Latest Developments
Table 133. Beijing Tiantan Biological Basic Information, Meningitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Tiantan Biological Meningitis Vaccine Product Offered
Table 135. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 136. Beijing Tiantan Biological Main Business
Table 137. Beijing Tiantan Biological Latest Developments
List of Figures
Figure 1. Picture of Meningitis Vaccine
Figure 2. Meningitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningitis Vaccine Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Meningitis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Meningitis Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Meningitis A+C
Figure 10. Product Picture of Meningitis ACWY135
Figure 11. Product Picture of Meningitis B
Figure 12. Global Meningitis Vaccine Sales Market Share by Type in 2021
Figure 13. Global Meningitis Vaccine Revenue Market Share by Type (2017-2022)
Figure 14. Meningitis Vaccine Consumed in Medical Care
Figure 15. Global Meningitis Vaccine Market: Medical Care (2017-2022) & (K MT)
Figure 16. Meningitis Vaccine Consumed in Hospital
Figure 17. Global Meningitis Vaccine Market: Hospital (2017-2022) & (K MT)
Figure 18. Global Meningitis Vaccine Sales Market Share by Application (2017-2022)
Figure 19. Global Meningitis Vaccine Revenue Market Share by Application in 2021
Figure 20. Meningitis Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Meningitis Vaccine Revenue Market Share by Company in 2021
Figure 22. Global Meningitis Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Meningitis Vaccine Revenue Market Share by Geographic Region in 2021
Figure 24. Global Meningitis Vaccine Sales Market Share by Region (2017-2022)
Figure 25. Global Meningitis Vaccine Revenue Market Share by Country/Region in 2021
Figure 26. Americas Meningitis Vaccine Sales 2017-2022 (K MT)
Figure 27. Americas Meningitis Vaccine Revenue 2017-2022 ($ Millions)
Figure 28. APAC Meningitis Vaccine Sales 2017-2022 (K MT)
Figure 29. APAC Meningitis Vaccine Revenue 2017-2022 ($ Millions)
Figure 30. Europe Meningitis Vaccine Sales 2017-2022 (K MT)
Figure 31. Europe Meningitis Vaccine Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Meningitis Vaccine Sales 2017-2022 (K MT)
Figure 33. Middle East & Africa Meningitis Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. Americas Meningitis Vaccine Sales Market Share by Country in 2021
Figure 35. Americas Meningitis Vaccine Revenue Market Share by Country in 2021
Figure 36. United States Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Meningitis Vaccine Sales Market Share by Region in 2021
Figure 41. APAC Meningitis Vaccine Revenue Market Share by Regions in 2021
Figure 42. China Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Meningitis Vaccine Sales Market Share by Country in 2021
Figure 49. Europe Meningitis Vaccine Revenue Market Share by Country in 2021
Figure 50. Germany Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Meningitis Vaccine Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Meningitis Vaccine Revenue Market Share by Country in 2021
Figure 57. Egypt Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Meningitis Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Meningitis Vaccine in 2021
Figure 63. Manufacturing Process Analysis of Meningitis Vaccine
Figure 64. Industry Chain Structure of Meningitis Vaccine
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...